Wyeth's Torisel approved for mantle cell lymphoma in EU
This article was originally published in Scrip
Executive Summary
The European Commission has approved Wyeth's cancer drug Torisel (temsirolimus) for relapsed and/or refractory mantle cell lymphoma, a rare condition which accounts for about 6% of cases of non-Hodgkin's lymphoma.